Overview

Update
IPO / Stock
Went Public on Mar 20, 2015 / NASDAQ:STDY
Total Equity Funding
$24.6M in 3 Rounds from 4 Investors
Headquarters:
Tel Aviv
Description:
SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.
Founders:
Categories:
Pharmaceutical, Therapeutics, Health Care
Website:
http://www.steadymed.com
Social:

Company Details

Update
Founded:
2005
Contact:
+97236449556
Employees:
11 - 50 | 7 in Crunchbase

SteadyMed Ltd. is a medical-device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

The company's products are pre-filled drug-infusion patches that will be sold in conjunction with a series of pharma and device companies. Specific applications of the device will be tailored in accordance with the requirements of the company's partners.

Funding Rounds (5) - $59.6M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2016$32M / Post Ipo Equity3
Feb, 2015$12.2M / Venture2
Apr, 2013$3M / Debt Financing1
Sep, 2012$10.4M / Venture2
Jan, 2009$2M / Series A1

Current Team (7)

Update

Competitors (1)

Update
  • Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.

Offices/Locations (2)

Update
  • Headquarters

    5 Oppenheimer St,

    Rehovot, 69719

    ISR

  • Office

    22 Raul Wallenberg St

    Tel Aviv, 69719

    ISR

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Memberships

Add Customers

Add Partners

Add Videos

Portions of this content provided by